G

Gert Meeus

AZ Groeninge

ORCID: 0000-0002-0649-6372

Publishes on Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Renal Diseases and Glomerulopathies. 22 papers and 626 citations.

22Publications
626Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Pseudomonas pickettii as a cause of pseudobacteremia
Gerda Verschraegen, Geert Claeys, Gert Meeus et al.|Journal of Clinical Microbiology|1985
Cited by 59Open Access

An outbreak of pseudobacteremia caused by Pseudomonas pickettii biovariant 1 is reported. The common source was the aqueous chlorhexidine solution prepared by the hospital pharmacy. The contamination problem caused by the antiseptic solution was eventually solved by a series of preventive measures.

A Prospective, Randomized, Double-Blind Crossover Study on the Use of 5% Citrate Lock versus 10% Citrate Lock in Permanent Hemodialysis Catheters
Gert Meeus, Dirk Kuypers, Kathleen Claes et al.|Blood Purification|2005
Cited by 27

Central venous catheters are used as permanent vascular access for chronic hemodialysis when construction of an arteriovenous fistula is not possible or contraindicated. We prospectively evaluated the efficacy and safety of a 5% citrate versus 10% citrate catheter lock for permanent single-lumen dialysis catheters in a double-blind, crossover study of 28 patients during 1,876 dialysis sessions. There was a slightly higher number of dialysis sessions with clot formation in the 5% citrate group; entirely attributable to the formation of small clots. There was no statistically significant difference in the formation of large clots, complete obstruction of the catheter or the need for urokinase between the 2 study groups. In view of the ongoing debate on the safety of high-concentration citrate catheter locks, we conclude that a 5% citrate lock is equally efficient in preventing catheter dysfunction compared with a 10% citrate lock and is therefore the preferred citrate catheter-locking solution.

A Case of IgG4-Related Sclerosing Disease With Retroperitoneal Fibrosis, Autoimmune Pancreatitis and Bilateral Focal Nephritis
Cited by 10

A 74-year-old male patient presented with progressive anorexia, cholestatic liver function tests, and a diffuse enlarged pancreas suggestive of a pancreatic carcinoma. There was a marked elevation of total immunoglobulin G4 (IgG4) in serum. Further investigation led to the diagnosis of IgG4-related sclerosing disease with involvement of the pancreas, retroperitoneal fibrosis, and bilateral focal nephritis. To our knowledge, this is the first report on these 3 clinical entities occurring in the same patient. A short review of the literature concerning autoimmune pancreatitis and retroperitoneal fibrosis is made, with special interest to the concept of IgG4-related pathology. This systemic disease can have several clinical manifestations: IgG4-positivity not only can be found in the pancreas, but also at the level of extrahepatic biliary ducts, gallbladder, salivary glands, retroperitoneal tissue, kidneys, ureters, and lymph nodes. Although further investigation is required to determine its exact pathophysiologic role, IgG4 seems to be an important key player. Abbreviations AIP - autoimmune pancreatitis, CA II - carbonic anhydrase II, CT - computed tomography, ERCP - endoscopic retrograde cholangiopancreaticography, HISORt - Histology Imaging Serology Other organ involvement Response to steroid therapy, IgG4 - immunoglobulin G (fourth subtype), IgG4-SD - IgG4-related sclerosing disease, IBD - inflammatory bowel disease, JPS - Japan Pancreas Society, MFS - multifocal fibrosclerosis, PET - positron emission tomography, ref. - reference value, RF - retroperitoneal fibrosis